RNS Number : 3349P
Impact Healthcare REIT PLC
21 May 2024
 

21 May 2024

Impact Healthcare REIT plc

("Impact" or the "Company")

Result of 2024 Annual General Meeting

The Board of Impact Healthcare REIT plc (ticker: IHR), the real estate investment trust which gives investors exposure to a diversified portfolio of UK healthcare real estate assets, in particular care homes, announces that at the Company's 2024 Annual General Meeting held today, all resolutions proposed at the AGM were voted on and passed by a poll by the Company's shareholders and the results of the poll, including the proxy votes received, are set out below.

 

Resolutions 1 to 14 (inclusive) were proposed as ordinary resolutions and resolutions 15 to 18 (inclusive) were proposed as special resolutions.

 


Resolution

Votes For*

%

Votes Against

%

Total votes validly cast

Total votes cast as % of issued share capital

Votes Withheld **

1

Receive the Annual Report and Financial Statements Year 31 December 2023

253,990,339

98.07%

5,000,000

1.93%

258,990,339

62.50%

454,356

2

Approve the directors' remuneration policy

259,266,401

99.98%

62,982

0.02%

259,329,383

62.58%

115,312

3

Approve the directors' remuneration report

259,268,331

99.98%

61,052

0.02%

259,329,383

62.58%

115,312

4

Approve the Company's Dividend Policy

259,439,371

100.00%

0

0.00%

259,439,371

62.61%

5,324

5

Re-elect Simon Laffin as a director

253,685,324

99.99%

18,692

0.01%

253,704,016

61.23%

5,740,679

6

Re-elect Rosemary Boot a director

259,323,378

99.95%

120,965

0.05%

259,444,343

62.61%

352

7

Re-elect Amanda Aldridge as a director

256,397,863

98.83%

3,046,479

1.17%

259,444,342

62.61%

353

8

Re-elect Chris Santer as a director

259,419,355

99.99%

24,988

0.01%

259,444,343

62.61%

352

9

Elect Cedi Frederick as a director

259,427,432

99.99%

16,911

0.01%

259,444,343

62.61%

352

10

To re-appoint BDO LLP as the Company's auditor

254,409,647

99.99%

26,900

0.01%

254,436,547

61.40%

5,008,148

11

To authorise the board of directors to determine the auditors remuneration

259,431,918

100.00%

8,629

0.00%

259,440,547

62.61%

4,148

12

To authorise the continuation of the Company

259,434,033

100.00%

1,810

0.00%

259,435,843

62.61%

8,852

13

To authorise the Directors to allot shares under section 551 Companies Act 2006

259,375,339

99.98%

49,328

0.02%

259,424,667

62.61%

20,028

14

Subject to the passing of resolution 11, to authorise the Directors to allot additional shares under section 551 Companies Act 2006

254,376,269

98.05%

5,048,398

1.95%

259,424,667

62.61%

20,028

15

Subject to the passing of resolution 12, to disapply statutory pre-emption rights under section 570 Companies Act 2006

240,489,252

92.70%

18,935,415

7.30%

259,424,667

62.61%

20,028

16

Subject to the passing of resolution 13, to disapply statutory pre-emption rights under section 570 Companies Act 2006

240,265,205

92.61%

19,167,961

7.39%

259,433,166

62.61%

11,529

17

To authorise the Company to make market purchase of its own ordinary shares

252,974,475

97.52%

6,427,561

2.48%

259,402,036

62.60%

42,659

18

To permit general meetings to be called on 14 days' notice

254,380,724

98.05%

5,063,617

1.95%

259,444,341

62.61%

354

 

Every shareholder has one vote for every Ordinary Share held. As at close of business on 17 May 2024, the share capital of the Company consisted of 414,368,169 Ordinary Shares with voting rights. The Company does not hold any shares in Treasury.

 

In accordance with Listing Rule 9.6.2, copies of all the resolutions passed, other than ordinary business, will be submitted to the National Storage Mechanism and will shortly be available for inspection at https://data.fca.org.uk/#/nsm/nationalstoragemechanism.

* Includes discretionary votes.

** A vote withheld is not a vote in law and is not counted in the calculation of the votes for or against a resolution.

 

FOR FURTHER INFORMATION, PLEASE CONTACT:

Impact Health Partners LLP

Andrew Cowley

via Maitland/AMO



JTC (UK) Limited - Company Secretary

Christopher Gibbons

0207 409 0181

Impact.CoSec@jtcgroup.com

 


H/Advisors Maitland (Communications advisor)

James Benjamin

07747 113 930

impacthealth-maitland@h-advisors.global

 

The Company's LEI is 213800AX3FHPMJL4IJ53.

 

NOTES:

Impact Healthcare REIT plc acquires, renovates, extends and redevelops high quality healthcare real estate assets in the UK and lets these assets on long-term full repairing and insuring leases to high-quality established healthcare operators which offer good quality care, under leases which provide the Company with attractive levels of rent cover.

The Company aims to provide shareholders with an attractive sustainable return, principally in the form of quarterly income distributions and with the potential for capital and income growth, through exposure to a diversified and resilient portfolio of UK healthcare real estate assets, in particular care homes for the elderly.

The Company's dividend policy is to maintain a progressive dividend that is covered by adjusted earnings.

On this basis, the target total dividend for the year ending 31 December 2024 is 6.95 pence per share*, a 0.18 pence increase over the 6.77 pence in dividends paid or declared per ordinary share for the year ended 31 December 2023.

The Group's Ordinary Shares trade on the main market of the London Stock Exchange, premium segment. The Company is a constituent of the FTSE EPRA/NAREIT index.

*     This is a target only and not a profit forecast. There can be no assurance that the target will be met and it should not be taken as an indicator of the Company's expected or actual results.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
RAGABMITMTMTBII